A reliable diagnosis of laxative abuse can only be reached by chemical analysis. We report a modified thin layer chromatography approach for the detection
and confirmation of over-the-counter colonic stimulant laxatives. Potential interference by dietary and drug components chemically similar to anthraquinones was investigated and the method was found to be specific in this respect. The diagnosis of magnesium laxative abuse is more difficult since magnesium is a component of body fluids. By inducing diarrhoea with magnesium salts in volunteers we have established that the diagnosis can be made by measuring magnesium concentrations in stool water, with 30 mmol/L being an appropriate cut-off concentration.
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Laxative-induced diarrhoea is a well-recognized clinical entity which is more common than is generally appreciated. For example, we found the prevalence of laxative abuse in patients attending gastroenterology clinics with diarrhoea to be 4%' and other authors quote figures of 10% and
Since patients usually deny ingestion of purgatives, diagnosis can only be achieved by chemical testing or by searching the patient's The latter approach is not ideal since it is only possible on an in-patient basis, is not foolproof, and has legal and ethical implications.
We have found that the faecal osmotic gap may be useful in excluding laxative induced diarrhoea (unpublished observations), but identification of laxatives is required to confirm the diagnosis. The colonic stimulant group of laxatives such as phenolphthalein and anthraquinones are readily identifiable in urine by thin layer chromatography (TLC). However, it is more difficult to diagnose the abuse of saline laxatives, such as salts of magnesium or sulphate, since the constituent ions of these substances are normally found in body fluids. Consequently a suitable sample must initially be selected and appropriate reference ranges determined.
This study addresses some aspects of the diagnosis of diarrhoea induced by colonic Correspondence: Dr A Duncan. stimulant and magnesium laxatives: modifications to TLC methods for detection of stimulant laxatives; the specificity of TLC with regard to dietary constituents and drugs with a structure similar to laxatives; selection of an appropriate sample for the diagnosis of magnesium laxative abuse and determination of suitable reference concentrations.
MATERIALS AND METHODS

Induction of diarrhoea by magnesium laxatives
In order to investigate the relatively rare abuse of saline laxatives, diarrhoea was induced in seven healthy volunteers by oral administration of magnesium hydroxide, and in one further volunteer by magnesium sulphate. Only magnesium-induced diarrhoea was investigated since over-the-counter sales of sodium sulphate are minimal' (personal communication) and the prevalence of diarrhoea induced by this compound is likely to be very low. After an overnight fast healthy volunteers were given an oral dose of 5.86 g magnesium hydroxide or 35 g magnesium sulphate (MgSO, . 7H20) in 100 mL water. Stools were collected separately for the next 36 h into plastic containers and stored immediately in a -10°C freezer. Urine was collected for 24 h following the administration of magnesium, and blood samples were taken at 0, 30 and 60min. Magnesium was measured in these samples and also in 18 stools collected by the eight volunteers. The study was approved by the Ethics Committee of the Greater Glasgow Health Board.
Stool samples were semi-thawed and homogenized without the addition of water. An aliquot was centrifuged at 20000g for 30min and the supernatant produced was filtered through paper filter discs (AP25 pre-filters, Millipore, UK). Concentrated hydrochloric acid (50 pL) was added to 1 mL supernatant to maintain magnesium solubility. The sample was then stored frozen until analysed.
To serve as controls 59 stool collections were obtained from 39 patients with other diarrhoea1 illnesses (18 with Crohn's disease, eight with infectious diseases, four with ulcerative colitis, three with irritable bowel syndrome, two with alcohol-induced diarrhoea and one each with chronic pancreatitis, post vagotomy diarrhoea, radiation enteritis, and tubular villous adenoma). Magnesium was measured in the faecal supernatants from these 59 samples and also in faecal homogenates and lyophylates of 36 of these collections.
Magnesium in 500 mg of faecal homogenate or 50 mg of lyophylate was solubilized by incubation (1 h at 150°C) with 5 mL concentrated nitric acid and 1 mL concentrated sulphuric acid. Nitric acid was removed by evaporation and 5 g/L lanthanum chloride was added to suppress phosphate interference, to a volume of 50 mL. Faecal supernatant was initially diluted 20-fold (control group) or 100-fold (magnesium group) with 5 g/L lanthanum chloride. Standards covering the concentration range 0-1.61 mmol/L were used. Samples and standards were diluted a further 70-fold with 5 g/L lanthanum chloride and magnesium was measured at 265 nm by atomic absorption spectrophotometry. Each sample was measured in duplicate. The intrabatch coefficient of variation for the assay was 7.9%.
The stool liquidity was expressed as the percentage of weight of supernatant divided by the total homogenate centrifuged. This figure was used as an indication of the severity of diarrhoea.
Effect of room temperature on magnesium concentration
Since p H falls in stool samples left at room temperature6-' and magnesium is more soluble in acidic conditions, it seemed possible that the magnesium concentration in stool supernatant might increase in samples left at room temperature. To test this supposition stool samples from five subjects were aliquotted and left at room temperature for 24 h before being centrifuged.
Modifications to TLC methods
The TLC system proposed by de Wolff e l al. ' requires two chromatography runs to separate the laxatives and so the simpler TLC method of Morton' was initially employed. This procedure was modified slightly to avoid staff exposure to chloroform and a second TLC solvent system was developed to provide a confirmatory separation.
Laxatives were deconjugated' and extracted into 20mL of diethyl ether. The main TLC solvent system used was ethyl acetate:toluene:glacial acetic acid (4: 16: 1) with methy1pentanone:hexane:glacial acetic acid (20:20:1) for confirmation. It is important that the plate is thoroughly dried before spraying; the coloration produced, by bisacodyl and phenolphathlein in particular, fades rapidly in the presence of acetic acid. The Rf 
and control groups.
Urinary magnesium outputs in magnesium
values and colours produced after visualization with sodium hydroxide are shown in Table 1 .
Specificity of TLC method
In those patients with a positive laxative screen, possible drug interference was investigated by TLC analysis of non-laxative drugs that the patients were known to be taking. Drugs which have previously been shown not to interfere were not tested.8 Two possible sources of urinary anthraquinone substances which could result in false positive TLC results were investigated. First, dietary constituents which are sometimes associated with diarrhoea (rhubarb, prunes, figs, liquorice and chilli) were analysed: lyophilized aliquots of 100 mg were oxidatively hydrolysed using 5 mL 4% periodic acid prior to TLC analysis. Secondly, the following drugs which are structurally related to anthraquinone laxatives were studied: chrysarobin, dithranol, podophyllum, plicamycin, daunorubicin, doxorubicin, and actinomycin D. Minimum patient doses were extracted and then separated by TLC. The suspicion that these drugs might interfere was strengthened by the fact that some colour the urine red as d o some laxatives.'"
RESULTS
Diagnosis of saline laxative abuse
The doses of saline laxative used provoked borborygmus in all subjects followed by one t o four loose bowel motions after 4 h.
Urinary excretion of magnesium is shown in Fig. 1 compared with 24 h concentrations in seven patients with diarrhoea and the normal 24 h value used in our laboratory. Plasma magnesium concentrations did not change significantly at 30 and 60min after oral administration of the magnesium salt.
There was overlap between magnesium concentrations in lyophylate and homogenate in both the control group and the magnesium group (Figs 2 and 3) . However, measurement of magnesium concentration in stool water produced clear resolution between the two groups (Fig. 4) . The maximum stool water magnesium concentration in the control group was 26mmol/L (mean = 9.1 mmol/L, SEM = 0.77) compared with a minimum concentration of 65 mmol/L (mean = 123 mmol/L, SEM = 6 -1) in the magnesiuminduced diarrhoea group. On the basis of these results 30 mmol/L was chosen as a suitable cutoff concentration.
Effect of room temperature on magnesium concentration
The results illustrated in Table 2 show that the magnesium concentration in supernatant increased significantly in samples that were not processed timeously.
Severity of diarrhoea and magnesium concentration
When the severity of diarrhoea (as assessed by the stool liquidity) was studied, no correlation with the magnesium concentration of faecal fluid was found (Spearman rank correlation coefficient, r s = -0.04). Of the volunteers studied, six produced more than one diarrhoea1 stool sample. It was therefore possible to assess the individual .:' 5. FIGLKt correlation between severity of diarrhoea and magnesium concentration. When the data was analysed in this way there was a moderate correlation between stool liquidity and magnesium concentrations (r, = 0 . 5 9 ) , implying a direct proportional relationship. The disagreement in results produced by these two statistical approaches, suggests that subjects had differing sensitivities to magnesium in the intestinal lumen.
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Specificity of TLC method
The following drugs ingested by patients with laxative induced diarrhoea were analysed for possible interference with the TLC methods and gave negative results: metoclopramide, loperamide, paracetamol, codeine, hydrochlorothiazide, bendrofluazide, bumetanide, amiloride, cyclopenthiazide, mefenamic acid, and hydroflumethiazide. Of the foodstuff analysed only rhubarb contained substances which on alkalinization produced the purplish coloration characteristic of anthraquinones. Three bands which could cause potential confusion were found with R, values of 0.69, 0.71 and 0 . 8 3 using the confirmatory solvent system. However, using the main solvent system the R, values were 0.64, 0.71 and 0-78 which did not correspond with mobilities of the standards. Urine samples from four volunteers who had taken 8 5 g (a generous helping) of rhubarb 8 h before, were all negative.
All of the anthraquinone-related drugs tested except plicamycin produced positive reactions by TLC but none gave a combination of R, value and colour reaction which was likely to cause confusion.
DISCUSSION
In this study a modified TLC method is reported which was found to be suitable for the detection of stimulant laxatives. A second confirmatory TLC system was incorporated in the procedure to minimize the possibility of false positive results.
It is particularly important that a laxative screening test is specific since a false positive could result in misdiagnosis of laxative abuse. While a patient would quite appropriately deny taking laxatives, the clinician would take such a denial as being in keeping with the diagnosis. The specificity cannot be determined in the conventional way by comparison with a definitive method since none exists. Although complete assurance cannot be given regarding the specificity of the TLC laxative screening test, de Wolff and colleagues have attempted to exclude the possibility of false positives due to drugs.8 They performed the screen on 73 commonly prescribed non-laxative drugs, none of which gave positive results. We have developed this work and have shown that dietary components that are associated with diarrhoea d o not interfere with the TLC screen.
Similarly, the seven non-laxative anthraquinonelike drugs tested were not liable to misinterpretation. Although our TLC procedure is apparently specific we normally exclude drugs as a possible cause of positive results by analysing any coadministered medication not previously tested.
In contrast to the anthraquinones it is unlikely that the presence of phenolphthalein or bisacodyl in the urine could be caused by anything other than laxative ingestion. These substances are neither naturally occurring nor food additives and so would not be expected t o be dietary constituents.
It is possible that laxative induced diarrhoea may be missed if purgatives are taken interm i t t e n t l~.~. '~ For this reason we request three urine samples taken at different times, except when the patient is known to have diarrhoea in which case a single specimen suffices.
If a routine TLC test is negative, as is normally the case, and clinical suspicion of laxative abuse is high then the possibility of magnesium laxative ingestion should be investigated. In order to identify magnesium laxative abuse, previous studies have suggested measuring magnesium in urine, stool homogenate or stool ~a t e r .~, " -~~ Although our findings show that a urinary magnesium output of more than 7 mmol/L may be consistent with magnesium induced diarrhoea, it cannot be considered as diagnostic. Similarly, no diagnostic information can be gleaned from the measurement of magnesium in the faecal homogenate, expressed either with respect to the wet weight or the dry weight of the sample. This is not surprising as the faecal output of magnesium depends on dietary magnesium intake and percentage absorption of magnesium. Since about 60 to 70% of magnesium consumed normally escapes a b~o r p t i o n , '~ a high dietary magnesium intake will give elevated outputs of faecal magnesium. In malabsorption syndromes hypomagnesaemia is a common finding and therefore an increased faecal output of magnesium would be expected. In contrast to urine and faecal homogenate samples, we found the measurement of magnesium in stool water distinctly separated magnesium induced diarrhoea from other causes of diarrhoea.
Results from our diarrhoea control group were considerably higher than those from a previous study14 in which the range of magnesium was found to be 0.1-1 1.3 mmol/L (mean= 2.1). The authors suggested a cut-off concentration of only 12mmol/L compared with our proposed 30mmoVL. In that report a small number of patients with undefined causes of diarrhoea were studied. The inclusion of patients with fat malabsorption in our control series may explain our higher reference range. This sub-group would in general be expected to give high faecal water concentrations of magnesium due to its decreased absorption and increased solubility, because of lower stool pH.
The volunteers used in the present study were given a single dose of purgative and so the resultant diarrhoea might not be typical of magnesium laxative abuse. It is also possible that the diarrhoea was more severe than in patients with purgative abuse. One volunteer, however, had only minimal diarrhoea with a faecal water magnesium concentration of 65 mmol/L which was still quite distinct from the control group. Five cases of magnesium induced diarrhoea are recorded in the literature in which the stool water magnesium concentrations were measured. Results of 166, 58, and 21 mmol/L were found by Morris and Turnberg in three successive daily stools from a patient with magnesium induced diarrhoea." The result of 21 mmol/L can be excluded from consideration because the patient added water to this stool in an attempt to mislead clinicians. In another case report elevated magnesium concentrations of 148 and 41 mmol/L were noted before and after fasting.'" In the other three studies stool water magnesium concentrations of 140 mmol/L, 120 mmol/L and 31 mmol/L were noted in patients abusing magnesium salt^.'.^.'^ Although by our criteria the last result is borderline, the diagnosis of magnesium abuse was probably correct since the patient was also abusing b i s a~o d y l .~ The present work also demonstrates that the magnesium concentration can rise significantly in stools which are left at room temperature. It is thus important either to process samples immediately or freeze them until analysis.
Less can be said about the predictive value of measuring saline laxatives. The severity of diarrhoea was found to correlate with the magnesium concentration suggesting that these purgatives act by an osmotic effect. Consequently, it is highly unlikely that a patient with saline laxative induced diarrhoea could have a normal concentration of the salt in stool water and there is little likelihood of producing false negative results. On the other hand, the constituents of saline laxatives are normal body ions and so a false positive result is feasible, albeit unlikely. In patients with only a slightly elevated result it would be sensible to exclude (a) malabsorption and (b) a dietary idiosyncrasy which might result in a high intake of magnesium (such as an addiction to dried fruit, brazil nuts or winkles!). Despite the existence of laxative induced diarrhoea as a clinical entity, we found that requests for laxative analysis are infrequently made.' Consequently the diagnosis may be missed with consequent financial and medical implications . 3 We believe the clinical biochemistry laboratory should provide and promote a laxative screening service. The information presented here gives guidelines for establishing such a service.
